SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-028506
Filing Date
2024-02-08
Accepted
2024-02-08 17:20:36
Documents
20
Period of Report
2024-02-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d745670d8k.htm   iXBRL 8-K 38211
2 EX-1.1 d745670dex11.htm EX-1.1 198612
3 EX-4.1 d745670dex41.htm EX-4.1 75480
4 EX-5.1 d745670dex51.htm EX-5.1 11502
5 EX-99.1 d745670dex991.htm EX-99.1 7303
9 GRAPHIC g745670g0208032652986.jpg GRAPHIC 1414
10 GRAPHIC g745670g0208032653139.jpg GRAPHIC 3252
  Complete submission text file 0001193125-24-028506.txt   550475

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA sana-20240207.xsd EX-101.SCH 2828
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE sana-20240207_lab.xml EX-101.LAB 18736
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sana-20240207_pre.xml EX-101.PRE 11692
21 EXTRACTED XBRL INSTANCE DOCUMENT d745670d8k_htm.xml XML 3772
Mailing Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102
Business Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102 (206) 701-7914
Sana Biotechnology, Inc. (Filer) CIK: 0001770121 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39941 | Film No.: 24610221
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)